Home ›
Trademark Categories ›
Pharmaceuticals ›
2008 ›
MA ›
MAGENZEL
Trademark search for:
MAGENZEL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2012-02-24 — Application filed
2012-02-28 — Application filed
2012-03-02 — Application filed
2012-06-05 — Assigned to examiner
2012-06-08 — Approved for pub - principal register
2012-06-27 — Notification of notice of publication e-mailed
2012-07-17 — Published for opposition
2012-07-17 — Official gazette publication confirmation e-mailed
2012-09-11 — Noa e-mailed - sou required from applicant
2013-03-11 — Sou teas extension received
2013-03-11 — Sou extension 1 filed
2013-03-11 — Sou extension 1 granted
2013-03-13 — Notice of approval of extension request e-mailed
2013-03-15 — Teas change of correspondence received
2013-06-06 — Attorney/dom.rep.revoked and/or appointed
2013-06-06 — Teas revoke/app/change addr of atty/dom rep received
2013-07-22 — Sou teas extension received
2013-07-22 — Sou extension 2 filed
2013-08-21 — Case assigned to intent to use paralegal
2013-08-22 — Sou extension 2 granted
2013-08-23 — Notice of approval of extension request e-mailed
2014-02-17 — Sou teas extension received
2014-02-17 — Sou extension 3 filed
2014-02-27 — Sou extension 3 granted
2014-02-28 — Notice of approval of extension request e-mailed
2014-08-14 — Sou teas extension received
2014-08-14 — Sou extension 4 filed
2014-08-25 — Sou extension 4 granted
2014-08-26 — Notice of approval of extension request e-mailed
2015-02-24 — Sou teas extension received
2015-02-24 — Sou extension 5 filed
2015-03-04 — Sou extension 5 granted
2015-03-05 — Notice of approval of extension request e-mailed
2015-06-08 — Teas change of correspondence received
2015-09-04 — Teas post publication amendment received
2015-09-04 — 44(e) petition - received
2015-09-11 — Notice of allowance cancelled
2015-09-15 — Petition to director - change basis - granted
2015-09-15 — Assigned to petition staff
2015-09-15 — Attorney review/decision on amendment required
2015-09-16 — Paper received
2015-09-30 — Notification of notice of publication e-mailed
2015-10-20 — Published for opposition
2015-10-20 — Official gazette publication confirmation e-mailed
2016-01-05 — Registered-principal register
2021-01-05 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2022-07-15 — Cancelled sec. 8 (6-yr)
2022-07-15 — Final status recorded
2022-08-03 — Attorney/dom.rep.revoked and/or appointed
2022-08-03 — Teas change of domestic representatives address
2022-08-03 — Teas change of owner address received
2022-08-03 — Teas change of correspondence received
2022-08-03 — Applicant/correspondence changes (non-responsive) entered
2022-08-03 — Teas revoke/app/change addr of atty/dom rep received
2022-08-03 — Teas withdrawal of attorney received-firm retains
Owner Information
GlaxoSmithKline Biologicals S.A.
GlaxoSmithKline Biologicals S.A.
GlaxoSmithKline Biologicals S.A.
Correspondent
Christopher M. Hanes GSK
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
